Compass Minerals,
Overland Park, Kan., reported net income from continuing operations of $32.9
million ($0.96 per diluted share) on sales of $426 million, compared to the
year-ago $33.9 million ($0.99 per share) and $346.9 million, respectively.
Continuing businesses include its Salt and Plant Nutrition segments (formerly
Plant Nutrition North America). Operating earnings were $63.6 million, up from
$45.4 million Adjusted EBITDA was $97.3 million, up from $75.1 million.
Discontinued
businesses, which have been or are being sold, include the North America
micronutrient business and the South American plant nutrient business.
Including these businesses, Compass had a net loss of $223.6 million ($6.60 per
share), compared to year-ago income of $27.6 million ($0.80 per share).
“On
the heels of a challenging year, we are pleased to have come out of the gate in
2021 with a very productive first quarter, while concurrently making meaningful
progress executing on our strategic priorities,” said Kevin Crutchfield, President
and CEO. “Our relentless focus on optimization has translated into
improved per-unit operating costs within our Salt segment. In addition,
continued solid demand for our Protassium+ product underpins our position as
the North American SOP market leader.
“We
also continue to focus on strengthening our balance sheet, which is expected to
be aided by the proceeds from the sale agreement for our South America
specialty plant nutrition business and the completed sale of certain North
America micronutrient assets,” he added. “Our intent moving forward is to
concentrate on our advantaged core assets and selectively pursue strategic
opportunities for growth.”
Plant Nutrition first-quarter
revenue totaled $54.2 million, down 4 percent from prior-year results. Sales
volumes and average selling prices each decreased approximately 2 percent
compared to first-quarter 2020 results. This was partially offset by a 9
percent improvement in per-unit logistics costs, primarily driven by a significantly
higher mix of direct customer shipments compared to the same period a year ago.
First-quarter operating
earnings declined $2.2 million from the first quarter of 2020 to $4.4 million,
which reflects higher operating costs per ton, while EBITDA totaled $13.2
million compared to $16.4 million in the prior-year period.
On May 4, 2021, the company
successfully closed its previously announced North America micronutrient sale
to Koch Agronomic Services, Wichita, for approximately $60 million, subject to
a closing working capital adjustment.
Company-wide, Compass gives
guidance of full-year adjusted EBITDA of $270-$295 million.
Compass expects Plant
Nutrition to see a modest year-over-year decrease in second-quarter sales
volumes, with slightly higher average SOP selling prices compared to the
year-ago period. It puts second-quarter segment EBITDA between $8-$13 million
and revenue $40-$50 million. Full-year volumes are put at 350-380,000 st.
The company expects
second-quarter Salt segment revenue to benefit from a mix-driven average
selling price improvement, partially offsetting anticipated higher
year-over-year logistics costs and sales mix related per-unit operating costs.
Second-quarter segment EBITDA is put at $37-$47 million and revenue $110-$135
million. Full-year volumes are expected at 11.5-12.3 million.
Plant Nutrition
|
1Q-21
|
1Q-20
|
Sales ($/M)
|
54.2
|
56.4
|
Operating
Earnings ($/M)
|
4.4
|
6.6
|
EBITDA ($/M)
|
13.2
|
16.4
|
Sales Volumes
(000 st)
|
94
|
96
|
Avg Sales Price
($/st)
|
579
|
590
|
Salt
|
1Q-21
|
1Q-20
|
Sales ($/M)
|
369
|
287.8
|
Operating
Earnings ($/M)
|
80.1
|
56.9
|
EBITDA ($/M)
|
98.1
|
71.5
|
Sales Volumes
(000 st)
|
5,028
|
3,573
|
Avg Sales Price
($/st)
|
73.38
|
80.53
|